Skip to main content
GKOS
NYSE Industrial Applications And Services

Officer Joseph Gilliam Plans $10.8M Stock Sale Near 52-Week High

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$182.235
Mkt Cap
$10.749B
52W Low
$73.16
52W High
$184
52W Position info
149% above low
Off High info
at 52W high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

GKOS has more than doubled off its 52-week low of $73.16 on light trading volume (0.2× avg).

Summary

Glaukos officer Joseph Gilliam plans to sell $10.8 million in shares acquired via option exercise, with the stock near its all-time high after strong Q2 results.


Key Events · Ownership and Investor Activity · GKOS

  • Officer Plans $10.8M Share Sale

    Joseph E. Gilliam, an officer, filed Form 144 to sell 60,000 shares worth approximately $10.78 million, acquired via same-day option exercise.

  • Sale Near 52-Week High

    The planned sale comes with the stock at $182.235, just below the 52-week high of $184.00, following a 50% YoY revenue surge and raised guidance.

  • Part of Ongoing Insider Distribution

    This is the latest in a series of insider sales over the past 90 days, with net open-market sales of $6.0 million by two insiders prior to this filing.

  • Discretionary Sale, Not Pre-Planned

    No 10b5-1 plan is indicated, meaning the sale is at the officer's discretion, which can be a stronger signal than automated sales.


Analysis · GKOS · Industrial Applications And Services

Officer Joseph E. Gilliam filed to sell 60,000 shares worth approximately $10.8 million, acquired via same-day option exercise. The sale represents about 0.1% of outstanding shares and comes as the stock trades near its 52-week high of $184.00, following a strong Q2 earnings beat and raised guidance. While the dollar amount is significant, the percentage of market cap is modest, and the sale is part of a pattern of insider distribution over the past 90 days. The filing does not indicate a 10b5-1 plan, so this is a discretionary sale, which carries more weight than a pre-planned transaction.

At the time of this filing, GKOS was trading at $182.24 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $10.7B. The 52-week trading range was $73.16 to $184.00. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

GKOS - Latest Insights

GKOS
Jul 29, 2026, 5:06 PM EDT
Filing Type: 10-Q
Importance Score:
8
GKOS
Jul 29, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
8
GKOS
Jul 29, 2026, 4:05 PM EDT
Source: BusinessWire
Importance Score:
8
GKOS
Jul 27, 2026, 7:00 AM EDT
Source: BusinessWire
Importance Score:
7
GKOS
Apr 30, 2026, 6:11 AM EDT
Source: Wiseek News
Importance Score:
8